The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer

BACKGROUND: Tamoxifen is important in the adjuvant treatment of hormone-sensitive breast cancer and substantially reduces recurrence; however, almost 50% of patients are non-compliant mainly due to side-effects. The aim of this study was to investigate whether endoxifen-guided tamoxifen dose reducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Buijs, S.M., Hoop, E. Oomen-de, Braal, C.L., van Rosmalen, M.M., Drooger, J.C., van Rossum-Schornagel, Q.C., Vastbinder, M.B., Koolen, S.L.W., Jager, A., Mathijssen, R.H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024121/
https://www.ncbi.nlm.nih.gov/pubmed/36753991
http://dx.doi.org/10.1016/j.esmoop.2023.100786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024121/
https://www.ncbi.nlm.nih.gov/pubmed/36753991
http://dx.doi.org/10.1016/j.esmoop.2023.100786

Ejemplares similares